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Abstract
Objective: Moderate fish intake in early pregnancy is associated with decreased risk of preterm 
birth (PTB). Obesity during pregnancy is characterized by inflammation and insufficiency of 
essential fatty acids. The objective of this study was to measure the association between fish intake 
during pregnancy and risk of recurrent spontaneous (s)PTB among lean, overweight and obese 
women.
Design: This is secondary analysis of a randomized controlled trial of omega-3 fatty acid 
supplementation for recurrent PTB prevention, 2005–6. The primary exposure was fish intake at 
time of enrollment (16–22.9 weeks gestation). The primary outcomes were sPTB <37 weeks and 
sPTB < 35 weeks. Maternal pre-pregnancy body mass index was treated as an effect modifier.
Subjects: 852 women were included, 47% were lean, 25% overweight and 28% obese.
Results: In this cohort, among lean, but not overweight or obese women, ≥ 1 serving of fish per 
week was associated with decreased frequency of sPTB < 37 weeks compared with < 1 serving of 
fish per week (45.1 vs. 27.5%, p = 0.001) and spontaneous PTB < 35 (21.4 vs 11.6%, p =0.01). In 
adjusted models, as fish intake increased, the predicted probability of sPTB decreased in lean 
women but increased in overweight and obese women (p for interaction <0.10).
Conclusion: Fish intake was associated with lower probability of sPTB in lean women and 
higher probability in obese women. These findings warrant further investigation to understand the 
dietary or metabolic factors associated with obesity that may modulate benefit of fish intake 
during pregnancy.
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Introduction
The American College of Obstetricians and Gynecologists (ACOG) recently revised 
guidelines to recommend 2–3 servings of low mercury fish and/or seafood per week for 
pregnant women and those who may become pregnant.1 In observational studies, moderate 
fish intake (1–3 serving/weeks) has been associated with decreased risk of PTB2, 3 and 
improved childhood neurodevelopmental outcomes.4 However, randomized controlled trials 
(RCTs) of fish oil supplementation among women at high risk of recurrent PTB have shown 
conflicting results.2, 5 Fish and fish oil intake have been hypothesized to improve perinatal 
outcomes through immunomodulation and anti-inflammatory characteristics of omega-3 
fatty acids.6–9 Maternal obesity during pregnancy is associated with a chronic, pro-
inflammatory state and a circulating insufficiency of certain antioxidant dietary components, 
particularly essential fatty acids.10–13 Thus, there is biologic plausibility that fish intake and 
omega-3 supplementation may impact pregnancy outcomes of obese women differently than 
non-obese women.
Given the paucity of data surrounding the relationship between maternal BMI, fish intake, 
omega-3 fatty acid status and pregnancy outcomes, we sought to examine whether maternal 
obesity or overweight modifies the association between fish intake and PTB risk. We 
hypothesized that obese and overweight women would need higher fish intake to obtain 
similar PTB risk reduction compared to lean women.
Methods
Study design
This is a secondary analysis of the Maternal Fetal Medicine Unit’s Omega-3 trial. This was a 
randomized, double-blind, placebo controlled trial of omega-3 fatty acid supplementation 
among women with one or more prior spontaneous PTB. The details of this study are 
described elsewhere.2 Briefly, this trial was conducted at 13 U.S. sites from January 2005-
October 2006. Women were included in the trial if they had a previous spontaneous PTB of 
a singleton infant between 20.0–36.9 weeks or preterm premature rupture of membranes 
(PPROM). Women were recruited for the trial at 16–22.9 weeks gestation. Women were 
excluded from the trial for major fetal anomaly, more than 500 mg of fish oil 
supplementation in the previous month, allergy to fish, major maternal medical co-
morbidity, planned or current cerclage or planned delivery at an outside institution or prior to 
37 weeks. All women in this trial were receiving weekly 250 mg 17-α progesterone 
injections for PTB prevention. Women were randomized to daily placebo or to the study 
drug, 1,200 mg eicosapentaenoic acid (EPA) and 800 mg docohexaenoic acid (DHA), for a 
total of 2000 mg of omega-3 long chain polyunsaturated fatty acids. At time of 
randomization and at 25–28 weeks, women were asked detailed information on frequency of 
fish intake using the same tool at both time points. At randomization, women were asked 
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about fish intake since the beginning of pregnancy until randomization. At 25–28 weeks, 
women asked about fish intake from randomization. Questions were developed specifically 
for this study. During data collection, women reported frequency of serving of any type of 
fish as never or < one/month, 1–3/month, 1/week, 2–4/week, 5–6/week, 1/day, 2–3/day, 4–
5/day or ≥6/day. After data collection, all responses were converted to servings/week. The 
questionnaire also assessed types of fish women consumed at randomization including 
canned tuna, dark meat fish, shellfish and other fish. Women self-reported their pre-
pregnancy weight and height was abstracted from the medical chart and used to calculate 
pre-pregnancy BMI. We included women with known pre-pregnancy BMI, early pregnancy 
fish intake and gestational age at delivery.
Plasma samples (at randomization) were snap frozen and shipped to a central laboratory for 
individual measurement using previously described methods.14 The concentrations of four 
omega-3 fatty acids (EPA, DHA, alpha-Linolenic acid, eicosatrienoic acid). The 
concentrations of four n3 FAs (EPA, DHA, alpha-Linolenic acid, eicosatrienoic acid) were 
assayed. Omega-3 fatty acids were calculated by adding the individual values of the 
constituent fatty acids.
Statistical analysis
Our primary exposure was self-reported fish intake (servings/week) in early pregnancy (< 22 
weeks gestation) before randomization to study supplement. Our primary outcomes were 
spontaneous PTB < 37 weeks and spontaneous PTB <35 weeks. We categorized maternal 
pre-pregnancy BMI by World Health Organization standards as lean (BMI < 25 kg/m2), 
overweight (25–29.9 kg/m2) or obese (≥ 30 kg/m2), and BMI category was treated as an 
effect modifier.
Klebanoff et al have previously described maternal demographics and clinical characteristics 
in this cohort by fish intake in early pregnancy.6 To inform this analysis, we compared 
maternal demographics, clinical characteristics and fish intake in early pregnancy by BMI 
category. Categorical variables were assessed using chi square tests. We assessed normality 
of continuous variables using the Shapiro-Wilk test. We used ANOVA (for normally 
distributed outcomes) and Kruskal-Wallis (for non-normally distributed outcomes) to assess 
differences in continuous outcomes, as appropriate. To assess the association between fish 
intake, BMI and PTB, we constructed scatterplots for each BMI category. We plotted 
servings per day of fish on the x axis, and probability of PTB on the Y axis, using LOESS 
(local polynormial regression) curves. This methodology was previously utilized in a 
planned secondary analysis of this trial.6
Based on the appearance of the scatterplot and inflection points, we quantified the 
association between fish intake and outcomes using an adjusted multivariable logistic 
regression model with an interaction term between fish intake and BMI category. Interaction 
terms were considered significant if p<0.1.15 Based on the previous secondary analysis of 
this trial which found that age, race, education, smoking in early pregnancy (categorically), 
number of prior previous PTB and gestational age at earliest PTB (continuously) were 
confounders of associations between fish intake and spontaneous PTB, we included these 
SMID et al. Page 3













covariates in our model a priori.6 Treatment group assignment (active supplement/placebo) 
was examined as an effect modifier, but the interaction p was not indicative of significant 
effect modification (p>0.1), so all analyses are presented with treatment groups combined, 
with additional adjustment for treatment group. We then determined predicted probabilities 
and 95% confidence intervals (CI) of PTB by fish intake within each BMI category.
We assessed the correlation of fish intake in early pregnancy (before randomization) and in 
late pregnancy (from randomization to 25–28 weeks) within each BMI category to 
determine if fish intake changed over course of pregnancy. We also assessed the correlation 
of early pregnancy fish intake and early pregnancy erythrocyte omega-3 fatty acid (as a 
percentage of all fatty acids) using Spearman’s correlations (due to non-normal distribution 
of omega-3 fatty acid).
We used adjusted linear regression to assess the association between fish intake and omega-3 
fatty acid stratified by BMI group. We then performed multivariable logistic regression to 
assess if omega-3 fatty acid and fish intake in early pregnancy were associated spontaneous 
PTB < 37 weeks, after adjustment for confounders. We tested whether fish intake modified 
the association of omega-3 fatty acids and PTB < 37 weeks stratified by BMI group using 
the Breslow Day test.
Analyses were performed using Stata 14.0 (College Station, Texas).
Results
Population
All women (n=852) in the parent study met inclusion criteria for our study. In the entire 
cohort, 47% of women were lean, 25% were overweight, and 28% were obese. Compared 
with lean women, obese and overweight women were more likely to be non-Hispanic black, 
have less than 12 years of education and to have gestational diabetes in the current 
pregnancy (p<0.001, Table 1). In their prior PTB, obese and overweight women had a lower 
median gestational age compared with lean women (p=0.002). The majority of women 
(70.3%) reported consuming some fish since the beginning of pregnancy; and nearly half of 
all women reported consuming at least one serving of fish per week. There was no 
difference by BMI category in women’s intake of tuna, dark meat or shellfish per week. 
However, obese women had greater intake per week of “other fish” compared with 
overweight and lean women. “Other fish” may have included non-oily fish (e.g. cod, 
haddock, Pollack) and processed/fried fish, however, further characterization is not 
available.
Fish intake and PTB
Among lean women, at least one serving of fish per week (compared to less than one serving 
of fish per week) was associated with decreased frequency of spontaneous PTB < 37 weeks 
(<1 serving: 45.1% vs. ≥ 1 serving: 27.5%, p = 0.001) and spontaneous PTB < 35 weeks 
(21.4 vs 11.6%, p =0.01) (Table 2). However, neither the frequency of spontaneous PTB < 
37 weeks nor < 35 weeks varied by fish intake among overweight or obese women.
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In multivariable logistic regression models for spontaneous PTB, the likelihood ratio test for 
models with and without interaction terms between maternal BMI group and fish intake was 
significant (p=0.03). In pairwise comparisons, interaction term was significant for obese 
compared with lean women (p=.04), but not overweight women compared with lean women 
(p=0.19). In other words, the association between fish intake and spontaneous PTB is 
different for lean and obese women but not between lean and overweight women. To 
increase interpretability of our models, we present the predicted probability of spontaneous 
preterm < 37 weeks by fish intake among lean, overweight and obese women (Figure 1). 
Among lean women, increasing fish intake was associated with a lower predicted probability 
of spontaneous PTB<37 weeks. However, among obese women, the relationship was in the 
opposite direction – as fish intake increased, predicted probability of PTB < 37 weeks also 
increased. For example, among lean women who consumed no fish in early pregnancy, the 
predicted probability of spontaneous PTB < 37 weeks was 39% (95% CI 33–46%) compared 
with 31% (95% CI 23–39%) for overweight women and 29% (95% CI 21–37%) for obese 
women. At two servings of fish per week, predicted probability of spontaneous PTB was 
similar among lean (32%, 95% CI 24–38%), overweight (30%, 95% CI 23–38%) and obese 
women (33%, 95% CI 27–42%). However, at four servings of fish per week, predicted 
probability of spontaneous PTB continued to decrease among lean women (25%, 95% CI 
14–35%), stayed approximately the same among overweight (30%, 95% CI 15–45%) and 
increased among obese women (41%, 95% CI 26–56%). These differences were more 
pronounced for predicted probabilities of spontaneous PTB < 35 weeks (Figure 2).
We further evaluated the association between fish intake and systemic fatty acid 
concentrations. Measures of fish intake at baseline and at the second study visit (25–28 
weeks) were highly correlated (rho =0.66, p <0.001) and were similar in each BMI category. 
Of the entire cohort, 82% (n= 696) of women had available erythrocyte omega-3 fatty acid 
concentrations at baseline. Fish intake and erythrocyte omega-3 concentrations at baseline 
were correlated overall (rho = 0.22, p <0.001). When we stratified by BMI, we found 
correlations among lean women (rho=0.28, p<0.001) and overweight women (rho=0.17, 
p=0.03) but not among obese women (rho=0.12, p=0.10). In adjusted linear regression, 
higher fish intake was associated with higher omega-3 fatty acid concentrations in each BMI 
group, but to a lesser extent among obese women (lean β 0.23, 95% 0.11–0.35; overweight 
β 0.18 95% CI 0.03–0.34; obese β 0.13 95% CI 0.01–0.25). Although fish intake was 
associated with omega-3 fatty acid concentrations at baseline, these concentrations were not 
associated PTB in any BMI category (interaction terms all p>0.1).
Discussion
In women with a history of a prior spontaneous PTB, we found that increasing fish intake 
appears to have a protective association with recurrent PTB among lean women only. 
Among lean women, higher fish intake was associated with a reduced predicted probability 
of PTB < 37 weeks; among obese women greater fish intake was associated with higher 
predicted probability of PTB. These results are contrary to our initial hypothesis. With a 
higher dose of fish, lean women continued to have a decrease in recurrent PTB, overweight 
women had no change in recurrent PTB, and obese women had higher recurrent PTB risk. 
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These differences could be explained by underlying maternal metabolic milieu, or 
differences in type of fish consumed by lean, overweight and obese women.
Our findings confirm and extend earlier work on associations between fish intake and 
recurrent PTB. Previous studies, including the planned secondary analysis of this parent 
study, have found that moderate intake of fish in early pregnancy is associated with 
decreased risk of any PTB.63, 7, 16 However, while the majority of these studies control for 
BMI, none of these studies investigate the extent to which BMI modifies the association 
between fish intake and PTB.
We and others have described the metabolic differences between obese and lean pregnant 
women, including higher inflammation, oxidative stress and lower omega-3 fatty acids and 
other nutritional antioxidant defenses.10–13, 17 It is possible that the benefits of fish intake 
did not outweigh these metabolic risk factors in obese women, but did improve overall 
metabolic health in lean women. This is supported by our observation that fish intake in 
early pregnancy is associated with erythrocyte omega-3 fatty acid concentrations in lean and 
overweight, but not obese women. However, omega-3 concentration was not associated with 
odds of PTB, suggesting that fish intake may be acting through a pathway other than 
omega-3 fatty acid levels. It has been postulated that other constituents of fish, such as 
selenium, iodine or vitamin D, may cumulatively or individually confer benefit.17 Another 
potential explanation of our findings was that although obese women ate more fish in early 
pregnancy than lean women, the types of fish or fish preparations that obese women 
consumed did not have anti-inflammatory properties or metabolic health benefits. For 
example, farmed salmon cooked with dry heat (grilling, pan-frying, broiling, oven baking) 
contains 4023 mg of omega-3 fatty acids and 1185 mg of omega-6 fatty acids while fried 
catfish contains 501 mg of omega-3 fatty acids and 2276 omega-6 fish acids.18, 19, 19 The 
omega-6 to omega-3 fatty acid ratio is an established marker of systemic inflammatory 
status.20, 21 The metabolism of omega-6 fatty acids (linoleic acid and arachidonic acid) 
increases the release of pro-inflammatory eicosanoids into systemic circulation; in contrast, 
metabolism of omega-3 fatty acids (docosahexaenoic acid and eicosapentaenoic acid) 
increases anti-inflammatory lipid mediators.22 It is plausible that if obese women are 
consuming higher amounts of fish that are higher in omega-6 FAs (e.g. farmed tilapia or 
catfish) and/or cooking with methods such as frying in omega-6 rich oils, this may increase 
their omega-6/omega-3 ratio and potentially explain the observed association of fish intake 
and PTB in obese women. Future studies should seek to delve more deeply into the 
metabolic and dietary mechanisms that may underlie the observed associations.
Our study has several strengths. The parent study included a racially and geographically 
diverse population of women with a history of PTB receiving standard-of-care 17-alpha 
hydroxyprogesterone caproate, increasing generalizability. The design of the parent study 
allowed detailed prospective collection of data regarding our exposure and outcome, 
including careful differentiation between spontaneous and indicated PTB. We have complete 
data on fish intake, pre-pregnancy BMI and gestational age at delivery for all women 
included in the trial, reducing the risk of selection bias. Perhaps our study’s most important 
strength is our inclusion of maternal BMI as an effect modifier; other studies assessing the 
relationship between fish intake and PTB have either not included maternal BMI in their 
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models or adjusted for BMI as confounder.2,5,7,20,21 In contrast to other studies of fish intake 
and PTB,3, 7, 16 we also have baseline assessments of omega-3 erythrocyte percentage.
Our findings must be interpreted in the context of the study design. Because this cohort of 
women all had a prior spontaneous PTB, these results may not be generalizable to women 
who have not had a previous PTB. Data on fish intake were self-reported. We do not have 
information about how fish were prepared (ie baked, broiled, fried) or types of oils used. Our 
study also did not assess mercury levels, which have been associated with PTB in other 
studies.16 We also do not have detailed information about other foods such as processed fatty 
foods and sugars or indicators of overall diet quality including amounts of fresh fruit and 
vegetable intake, which may mediate the associations that we observed.
We found that among lean pregnant women at high risk of recurrent PTB, higher fish intake 
was associated with a lower risk of PTB. This protective association was not observed 
among overweight and obese women. Our study does not address the pathophysiological 
mechanism underlying the effect modification of maternal BMI on fish intake and recurrent 
spontaneous PTB. We suggest that, in light of our findings, future studies may seek to 
understand these mechanisms including the contribution of certain types of fish or other 
dietary components to an altered omega3/6 ratio, the role of mercury and other 
environmental contaminants and nutrients such as vitamin D, iodine and selenium. Our 
findings suggest that future studies should carefully examine dietary and metabolic factors 
associated with obesity to better understand how maternal obesity may affect risk for 
spontaneous PTB. If our findings are replicated, this research could support more targeted 
dietary recommendations regarding choice of fish and fish preparation for obese women.
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Adjusted predicted probability of spontaneous preterm birth <35 weeks and fish intake 
among lean, overweight and obese women (n=852). Models include maternal age, race, 
education, smoking, number of prior previous PTB, gestational age at earliest PTB and 
treatment group, with predictors held at the mean. P value for interaction = 0.04
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Adjusted predicted probability of spontaneous preterm birth <37 weeks and fish intake 
among lean, overweight and obese women (n=852). Models include maternal age, race, 
education, smoking, number of prior previous PTB, gestational age at earliest PTB and 
treatment group with predictors held at the mean. P value for interaction = 0.03
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Table 1.
Maternal characteristics by pre-pregnancy obesity in MFM Omega-3 Trial (n=852)
Maternal pre-pregnancy BMI (kg/m2) P value
#
Total < 25 25–29.9 ≥30
N=852 N=404 n=208 n=240
Maternal characteristic 0.94
















Race/ethnicity: N (%) <0.001
 Non-Hispanic White 419 (49.2) 243 (60.3) 89 (42.8) 87 (36.3)
 Non-Hispanic Black 287 (33.7) 95 (23.6) 78 (37.5) 114 (47.5)
 Hispanic 121 (14.2) 51 (12.7) 36 (17.3) 34 (14.2)
 Other 24 (2.8) 14 (3.5) 5 (2.4) 5 (2.1)
Gestational age at randomization (weeks) median(IQR) 19.6 (18.21) 19.6 (18,21) 19.7 (17,9, 21.6) 19.4 (18,20.9) 0.86
Parity (median, IQR) 2 (1,2) 1 (1,2) 2 (1,2.5) 2 (1,3) 0.002
Education <12 years n (%) 164 (19.3) 63 (15.7) 48 (23.1) 53 (22.1) 0.04
Married n(%) 628 (73.7) 306 (75.7) 152 (73.1) 170 (70.8) 0.38
Smoking n(%) 136 (160) 61 (15.1) 30 (14.4) 45 (18.8) 0.37
Drug use n(%) 18 (2.1) 8 (2.0) 5 (2.4) 5 (2.1) 0.94
Pre-gestational diabetes n(%) 16 (1.9) 6 (1.5) 3 (1.4) 7 (2.9) 0.38
Gestational diabetes n(%) 55 (6.5) 15 (3.7) 10 (4.8) 30 (12.5) <0.001
Prior delivery characteristics
≥ one prior preterm birth n(%) 247 (29.0) 111 (27.5) 68 (32.7) 68 (28.3) 0.39
Gestational age of earliest prior preterm birth (weeks), 
median IQR
32 (26, 34) 32 (28, 35) 31 (25, 34) 30 (25, 34) 0.0002
Fish intake in early pregnancy (<22 weeks)
Any fish at randomization n(%) 599 (70.3) 272 (67.3) 144 (69.2) 183 (76.3) 0.05
≥1 serving of fish/wk at baseline n(%) 423 (49.7) 189 (46.8) 98 (47.1) 136 (56.7) 0.04
Type of fish (grams/week)
(mean±standard deviation) *
Tuna 0.15 (±0.29) 0.15 (±0.31) 0.12 (±0.24) 0.18 (±0.32) 0.16
Dark meat fish (salmon, mackerel, sardines, bluefish, 
swordfish) 0.24 (± 0.68) 0.26 (± 0.73) 0.26 (± 0.26) 0.19 (± 0.53)
0.36
Other fish 0.14 (± 0.32) 0.12 (± 0.27) 0.15 (± 0.36) 0.19 (±0.35)** 0.02
Shellfish 0.10 (± 0.19) 0.10 (± 0.20) 0.09 (±0.19) 0.09 (±0.16) 0.87
*
Variables not normally distributed. The majority of women ate 0–1 servings/wk, median, IQR is 0 (0,0) for all groups. Mean and standard 
deviation are presented.
**
Obese compared to lean women p=0.01
#
P value for comparison of all three BMI categories
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